marijuana stocks news

NTRR Seeks Out Development Partner for Libido-Enhancing Inhaler

As part of its plan to deliver new products to capitalize on growth in a global nutraceuticals market forecast to reach $424 billion by 2017, Neutra Corp. (NTRR) announced today that the company is seeking out potential partners to help develop and market libido-enhancing inhaler technology.

NTRR believes that disposable inhaler technology is poised to become a new and better industry standard for a wide variety of supplements and nutraceuticals—including those developed to improve sexual function and desire in men. The company’s research indicates that a libido-boosting inhaler will be more effective and faster-acting than pills and other supplements on the market, and NTRR plans to be the first to offer such a product.

“Inhalation technology is going to be a game-changer in the nutraceuticals industry,” said NTRR CEO Chris Brown. “The market for supplements that enhance or improve sex for men is obviously enormous, and this is an innovation that is going to make a huge splash in this sector.”

NTRR is looking for potential partners experienced in marketing and developing inhaler technology as well as nutraceuticals. The new technology is one of several products that the company is developing to diversify its offerings and expand its earnings potential in the global nutraceuticals market.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPRF), INSYS Therapeutics, Inc. (INSY) and ENDEXX Corp. (EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contact:
Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$SIPC Awarded Supply Contract From Kona Gold Solutions, Inc.

Sipp Industries Awarded Supply Contract From Kona Gold Solutions, Inc. for Hemp…

Green Thumb Industries Inc. (GTBIF) to Open Rise Duncansville, Its 47th Retail Location, on June 30

Green Thumb Industries to Open Rise Duncansville, Its 47th Retail Location, on…

AbbVie Inc. (ABBV) RINVOQ® (upadacitinib) Receives Health Canada Approval

AbbVie’s RINVOQ® (upadacitinib) Receives Health Canada Approval as the First and Only…

$TRTC to Exhibit at the NCIA Cannabis Business Summit & Expo

Terra Tech Corp. to Exhibit at the NCIA Cannabis Business Summit &…